Differences in Circulating Angiogenic Biomarkers as Prognosticator for Outcome in Bevacizumab-Treated Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Patients: Translational Research

Autor: Batus, M., Pithadia, R., Kubasiak, J., Fhied, C., Ibrahem, Z., Melinamani, S., Fughhi, I., Lie, W., Basu, S., Fidler, M., Bonomi, P.D., Borgia, J.A.
Zdroj: In International Journal of Radiation Oncology, Biology, Physics 15 November 2014 90(5) Supplement:S75-S75
Databáze: ScienceDirect